MOH — authorised 22 August 1962
- Marketing authorisation holder: WYETH AYERST
- Status: likely_approved
🇮🇱 Grifulvin V in Israel
MOH authorised Grifulvin V on 22 August 1962
Marketing authorisation
Grifulvin V in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in Israel
Frequently asked questions
Is Grifulvin V approved in Israel?
Yes. MOH authorised it on 22 August 1962.
Who is the marketing authorisation holder for Grifulvin V in Israel?
WYETH AYERST holds the Israeli marketing authorisation.